论文部分内容阅读
恶性淋巴瘤是淋巴免疫系统恶性肿瘤的总称。淋巴组织是机体维持免疫功能的主要器官。因此恶性淋巴瘤的免疫病理的研究,不仅对恶性淋巴瘤的分类、诊断、治疗与预后判断,而且对进一步了解淋巴细胞增生疾病和免疫缺陷疾病的本质提供新的途径。每一种恶性淋巴瘤是T细胞、B细胞、单核吞噬细胞系某一特定分化阶段的恶性增生,从而瘤细胞都能显示各系分化特征的细胞膜标志和功能形态学特征,因此我们能把它作为恶性淋巴瘤免疫功能形态学分类的客观指标。淋巴细胞的分化、表面标志与恶性淋巴瘤的关系
Malignant lymphoma is a general term for lymphoid immune system malignancies. Lymphatic tissue is the body’s main organ to maintain immune function. Therefore, the study of immunopathology of malignant lymphoma not only provides a new way to further understand the nature of lymphoproliferative diseases and immunodeficiency diseases, but also not only the classification, diagnosis, treatment and prognosis of malignant lymphoma. Each of the malignant lymphomas is a malignant hyperplasia of T cells, B cells, and mononuclear phagocytes at a particular differentiation stage so that the tumor cells can display the cell membrane markers and functional morphological characteristics of the differentiation characteristics of each line, and thus we can It serves as an objective indicator of immune function morphological classification of malignant lymphoma. Differentiation of Lymphocytes, Surface Markers and Malignant Lymphoma